Abstract
Cutaneous T-cell lymphomas are a heterogeneous group of cutaneous non-Hodgkin's lymphomas. In the United States, the incidence of these diseases is rising faster than any other cancer. Environmental triggers may be important in the evolution of malignancy. Current therapy is reviewed with emphasis on a new retinoid, Targretin.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3 |
| Number of pages | 1 |
| Journal | Dermatology online journal [electronic resource] |
| Volume | 7 |
| Issue number | 1 |
| State | Published - Feb 2001 |
ASJC Scopus subject areas
- Dermatology